Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin i and incident atrial fibrillation

Michiel Rienstra, Xiaoyan Yin, Martin G. Larson, Joao Daniel T. Fontes, Jared W. Magnani, David D. McManus, Elizabeth L. McCabe, Erin E. Coglianese, Michael Amponsah, Jennifer E. Ho, James L. Januzzi, Kai C. Wollert, Michael G. Fradley, Ramachandran S. Vasan, Patrick T. Ellinor, Thomas J. Wang, Emelia J. Benjamin

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background We investigated whether circulating concentrations of soluble ST2, growth differentiation factor-15 (GDF-15), and high-sensitivity troponin I (hsTnI) are associated with incident atrial fibrillation (AF) and whether these biomarkers improve current risk prediction models including AF risk factors, B-type natriuretic peptide (BNP), and C-reactive protein (CRP). Methods We studied the relation between soluble ST2, GDF-15, and hsTnI and development of AF in Framingham Heart Study participants without prevalent AF. We used Cox proportional hazard regression analysis to examine the relation of incident AF during a 10-year follow-up period with each biomarker. We adjusted for standard AF clinical risk factors, BNP, and CRP. Results The mean age of the 3,217 participants was 59 ± 10 years, and 54% were women. During a 10-year follow-up, 242 participants developed AF. In age- and sex-adjusted models, GDF-15 and hsTnI were associated with risk of incident AF; however, after including the AF risk factors and BNP and CRP, only hsTnI was significantly associated with AF (hazard ratio per 1 SD of loge hsTnI, 1.12, 95% CI 1.00-1.26, P =.045). The c statistic of the base model including AF risk factors, BNP, and CRP was 0.803 (95% CI 0.777-0.830) and did not improve by adding individual or all 3 biomarkers. None of the discrimination and reclassification statistics were significant compared with the base model. Conclusion In a community-based cohort, circulating hsTnI concentrations were associated with incident AF. None of the novel biomarkers evaluated improved AF risk discrimination or reclassification beyond standard clinical AF risk factors and biomarkers.

Original languageEnglish (US)
JournalAmerican Heart Journal
Volume167
Issue number1
DOIs
StatePublished - Jan 2014
Externally publishedYes

Fingerprint

Growth Differentiation Factor 15
Troponin
Atrial Fibrillation
Troponin I
Brain Natriuretic Peptide
Biomarkers
C-Reactive Protein

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin i and incident atrial fibrillation. / Rienstra, Michiel; Yin, Xiaoyan; Larson, Martin G.; Fontes, Joao Daniel T.; Magnani, Jared W.; McManus, David D.; McCabe, Elizabeth L.; Coglianese, Erin E.; Amponsah, Michael; Ho, Jennifer E.; Januzzi, James L.; Wollert, Kai C.; Fradley, Michael G.; Vasan, Ramachandran S.; Ellinor, Patrick T.; Wang, Thomas J.; Benjamin, Emelia J.

In: American Heart Journal, Vol. 167, No. 1, 01.2014.

Research output: Contribution to journalArticle

Rienstra, M, Yin, X, Larson, MG, Fontes, JDT, Magnani, JW, McManus, DD, McCabe, EL, Coglianese, EE, Amponsah, M, Ho, JE, Januzzi, JL, Wollert, KC, Fradley, MG, Vasan, RS, Ellinor, PT, Wang, TJ & Benjamin, EJ 2014, 'Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin i and incident atrial fibrillation', American Heart Journal, vol. 167, no. 1. https://doi.org/10.1016/j.ahj.2013.10.003
Rienstra, Michiel ; Yin, Xiaoyan ; Larson, Martin G. ; Fontes, Joao Daniel T. ; Magnani, Jared W. ; McManus, David D. ; McCabe, Elizabeth L. ; Coglianese, Erin E. ; Amponsah, Michael ; Ho, Jennifer E. ; Januzzi, James L. ; Wollert, Kai C. ; Fradley, Michael G. ; Vasan, Ramachandran S. ; Ellinor, Patrick T. ; Wang, Thomas J. ; Benjamin, Emelia J. / Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin i and incident atrial fibrillation. In: American Heart Journal. 2014 ; Vol. 167, No. 1.
@article{28a27924225849e1b93ce9647d71dbdf,
title = "Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin i and incident atrial fibrillation",
abstract = "Background We investigated whether circulating concentrations of soluble ST2, growth differentiation factor-15 (GDF-15), and high-sensitivity troponin I (hsTnI) are associated with incident atrial fibrillation (AF) and whether these biomarkers improve current risk prediction models including AF risk factors, B-type natriuretic peptide (BNP), and C-reactive protein (CRP). Methods We studied the relation between soluble ST2, GDF-15, and hsTnI and development of AF in Framingham Heart Study participants without prevalent AF. We used Cox proportional hazard regression analysis to examine the relation of incident AF during a 10-year follow-up period with each biomarker. We adjusted for standard AF clinical risk factors, BNP, and CRP. Results The mean age of the 3,217 participants was 59 ± 10 years, and 54{\%} were women. During a 10-year follow-up, 242 participants developed AF. In age- and sex-adjusted models, GDF-15 and hsTnI were associated with risk of incident AF; however, after including the AF risk factors and BNP and CRP, only hsTnI was significantly associated with AF (hazard ratio per 1 SD of loge hsTnI, 1.12, 95{\%} CI 1.00-1.26, P =.045). The c statistic of the base model including AF risk factors, BNP, and CRP was 0.803 (95{\%} CI 0.777-0.830) and did not improve by adding individual or all 3 biomarkers. None of the discrimination and reclassification statistics were significant compared with the base model. Conclusion In a community-based cohort, circulating hsTnI concentrations were associated with incident AF. None of the novel biomarkers evaluated improved AF risk discrimination or reclassification beyond standard clinical AF risk factors and biomarkers.",
author = "Michiel Rienstra and Xiaoyan Yin and Larson, {Martin G.} and Fontes, {Joao Daniel T.} and Magnani, {Jared W.} and McManus, {David D.} and McCabe, {Elizabeth L.} and Coglianese, {Erin E.} and Michael Amponsah and Ho, {Jennifer E.} and Januzzi, {James L.} and Wollert, {Kai C.} and Fradley, {Michael G.} and Vasan, {Ramachandran S.} and Ellinor, {Patrick T.} and Wang, {Thomas J.} and Benjamin, {Emelia J.}",
year = "2014",
month = "1",
doi = "10.1016/j.ahj.2013.10.003",
language = "English (US)",
volume = "167",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin i and incident atrial fibrillation

AU - Rienstra, Michiel

AU - Yin, Xiaoyan

AU - Larson, Martin G.

AU - Fontes, Joao Daniel T.

AU - Magnani, Jared W.

AU - McManus, David D.

AU - McCabe, Elizabeth L.

AU - Coglianese, Erin E.

AU - Amponsah, Michael

AU - Ho, Jennifer E.

AU - Januzzi, James L.

AU - Wollert, Kai C.

AU - Fradley, Michael G.

AU - Vasan, Ramachandran S.

AU - Ellinor, Patrick T.

AU - Wang, Thomas J.

AU - Benjamin, Emelia J.

PY - 2014/1

Y1 - 2014/1

N2 - Background We investigated whether circulating concentrations of soluble ST2, growth differentiation factor-15 (GDF-15), and high-sensitivity troponin I (hsTnI) are associated with incident atrial fibrillation (AF) and whether these biomarkers improve current risk prediction models including AF risk factors, B-type natriuretic peptide (BNP), and C-reactive protein (CRP). Methods We studied the relation between soluble ST2, GDF-15, and hsTnI and development of AF in Framingham Heart Study participants without prevalent AF. We used Cox proportional hazard regression analysis to examine the relation of incident AF during a 10-year follow-up period with each biomarker. We adjusted for standard AF clinical risk factors, BNP, and CRP. Results The mean age of the 3,217 participants was 59 ± 10 years, and 54% were women. During a 10-year follow-up, 242 participants developed AF. In age- and sex-adjusted models, GDF-15 and hsTnI were associated with risk of incident AF; however, after including the AF risk factors and BNP and CRP, only hsTnI was significantly associated with AF (hazard ratio per 1 SD of loge hsTnI, 1.12, 95% CI 1.00-1.26, P =.045). The c statistic of the base model including AF risk factors, BNP, and CRP was 0.803 (95% CI 0.777-0.830) and did not improve by adding individual or all 3 biomarkers. None of the discrimination and reclassification statistics were significant compared with the base model. Conclusion In a community-based cohort, circulating hsTnI concentrations were associated with incident AF. None of the novel biomarkers evaluated improved AF risk discrimination or reclassification beyond standard clinical AF risk factors and biomarkers.

AB - Background We investigated whether circulating concentrations of soluble ST2, growth differentiation factor-15 (GDF-15), and high-sensitivity troponin I (hsTnI) are associated with incident atrial fibrillation (AF) and whether these biomarkers improve current risk prediction models including AF risk factors, B-type natriuretic peptide (BNP), and C-reactive protein (CRP). Methods We studied the relation between soluble ST2, GDF-15, and hsTnI and development of AF in Framingham Heart Study participants without prevalent AF. We used Cox proportional hazard regression analysis to examine the relation of incident AF during a 10-year follow-up period with each biomarker. We adjusted for standard AF clinical risk factors, BNP, and CRP. Results The mean age of the 3,217 participants was 59 ± 10 years, and 54% were women. During a 10-year follow-up, 242 participants developed AF. In age- and sex-adjusted models, GDF-15 and hsTnI were associated with risk of incident AF; however, after including the AF risk factors and BNP and CRP, only hsTnI was significantly associated with AF (hazard ratio per 1 SD of loge hsTnI, 1.12, 95% CI 1.00-1.26, P =.045). The c statistic of the base model including AF risk factors, BNP, and CRP was 0.803 (95% CI 0.777-0.830) and did not improve by adding individual or all 3 biomarkers. None of the discrimination and reclassification statistics were significant compared with the base model. Conclusion In a community-based cohort, circulating hsTnI concentrations were associated with incident AF. None of the novel biomarkers evaluated improved AF risk discrimination or reclassification beyond standard clinical AF risk factors and biomarkers.

UR - http://www.scopus.com/inward/record.url?scp=84890117718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890117718&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2013.10.003

DO - 10.1016/j.ahj.2013.10.003

M3 - Article

VL - 167

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1

ER -